Systemic T-cells demonstrate a tumour permissive response in breast cancer patients

被引：0
|
作者：
M. R. Kell
J. Connelly
D. C. Winter
D. Beddy
C. Canning
R. W. G. Watson
J. M. Fltzpatrick
M. Kerin
机构：
[1] Mater Misericordiae Hospital,Department of Surgery
[2] Conway Institute of Blomolecular and Biomedical Research,undefined
[3] University College Dublin,undefined
来源：
Irish Journal of Medical Science | 2002年 / 171卷 / Suppl 2期
关键词：
D O I：
10.1007/BF03170063
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] ROSETTE FORMING AND SUPPRESSOR T-CELLS IN HUMAN BREAST-CANCER
    GOUST, JM
    ROOF, BS
    FUDENBERG, HH
    CLINICAL RESEARCH, 1978, 26 (03): : A435 - A435
  • [22] INCREASE IN ACTIVATED T-CELLS AND REDUCTION IN SUPPRESSOR INDUCER T-CELLS IN SYSTEMIC-SCLEROSIS
    GUSTAFSSON, R
    TOTTERMAN, TH
    KLARESKOG, L
    HALLGREN, R
    ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (01) : 40 - 45
  • [23] GENE EXPRESSION OF CIRCULATING TUMOUR CELLS IN BREAST CANCER PATIENTS
    Boelke, E.
    Orth, K.
    Gerber, P. A.
    Lammering, G.
    Mota, R.
    Peiper, M.
    Matuschek, C.
    Budach, W.
    Rusnak, E.
    Shaikh, S.
    Dogan, B.
    Prisack, H. B.
    Bojar, H.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 (10) : 426 - 432
  • [24] Biomarkers characterization of circulating tumour cells in breast cancer patients
    Nadal, Rosa
    Fernandez, Ana
    Sanchez-Rovira, Pedro
    Salido, Marta
    Rodriguez, Maria
    Luis Garcia-Puche, Jose
    Macia, Marta
    Maria Corominas, Josep
    Delgado-Rodriguez, Miguel
    Gonzalez, Lucas
    Albanell, Joan
    Fernandez, Monica
    Sole, Francesc
    Antonio Lorente, Jose
    Jose Serrano, Maria
    BREAST CANCER RESEARCH, 2012, 14 (03)
  • [25] Gene expression of circulating tumour cells in breast cancer patients
    E Bölke
    K Orth
    PA Gerber
    G Lammering
    R Mota
    M Peiper
    C Matuschek
    W Budach
    E Rusnak
    S Shaikh
    B Dogan
    HB Prisack
    H Bojar
    European Journal of Medical Research, 14 (10)
  • [26] Biomarkers characterization of circulating tumour cells in breast cancer patients
    Rosa Nadal
    Ana Fernandez
    Pedro Sanchez-Rovira
    Marta Salido
    María Rodríguez
    José Luis García-Puche
    Marta Macià
    Josep Maria Corominas
    Miguel Delgado-Rodriguez
    Lucas Gonzalez
    Joan Albanell
    Mónica Fernández
    Francesc Solé
    José Antonio Lorente
    María José Serrano
    Breast Cancer Research, 14
  • [27] Validation of Systemic and Local Tumour Immune Response to Eribulin Chemotherapy in the Treatment of Breast Cancer
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Takada, Koji
    Morisaki, Tamami
    Kouhashi, Rika
    Yabumoto, Akimichi
    Tanaka, Sayaka
    Takashima, Tsutomu
    Ohsawa, Masahiko
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2020, 40 (06) : 3345 - 3354
  • [28] Chemotherapy-induced Changes and Immunosenescence of CD8+ T-Cells in Patients with Breast Cancer
    Onyema, Oscar Okwudiri
    Decoster, Lore
    Njemini, Rose
    Forti, Louis Nuvagah
    Bautmans, Ivan
    De Waele, Marc
    Mets, Tony
    ANTICANCER RESEARCH, 2015, 35 (03) : 1481 - 1489
  • [29] Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells
    Liu, Hsien
    Wang, Shih-Han
    Chen, Shin-Cheh
    Chen, Ching-Ying
    Lin, Tsun-Mei
    BMC CANCER, 2019, 19 (1)
  • [30] Autologous dendritic cells and activated cytotoxic T-cells as combination therapy for breast cancer
    Shevchenko, Julia A.
    Khristin, Alexander A.
    Kurilin, Vasily V.
    Kuznetsova, Maria S.
    Blinova, Darya D.
    Starostina, Natalya M.
    Sidorov, Sergey, V
    Sennikov, Sergey, V
    ONCOLOGY REPORTS, 2020, 43 (02) : 671 - 680
12345